RT Journal Article SR Electronic T1 Human Biodistribution and Radiation Dosimetry of 82Rb JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1592 OP 1599 DO 10.2967/jnumed.110.077669 VO 51 IS 10 A1 Srinivasan Senthamizhchelvan A1 Paco E. Bravo A1 Caroline Esaias A1 Martin A. Lodge A1 Jennifer Merrill A1 Robert F. Hobbs A1 George Sgouros A1 Frank M. Bengel YR 2010 UL http://jnm.snmjournals.org/content/51/10/1592.abstract AB Prior estimates of radiation-absorbed doses from 82Rb, a frequently used PET perfusion tracer, yielded discrepant results. We reevaluated 82Rb dosimetry using human in vivo biokinetic measurements. Methods: Ten healthy volunteers underwent dynamic PET/CT (6 contiguous table positions, each with separate 82Rb infusion). Source organ volumes of interest were delineated on the CT images and transferred to the PET images to obtain time-integrated activity coefficients. Radiation doses were estimated using OLINDA/EXM 1.0. Results: The highest mean absorbed organ doses (μGy/MBq) were observed for the kidneys (5.81), heart wall (3.86), and lungs (2.96). Mean effective doses were 1.11 ± 0.22 and 1.26 ± 0.20 μSv/MBq using the tissue-weighting factors of the International Commission on Radiological Protection (ICRP), publications 60 and 103, respectively. Conclusion: Our current 82Rb dosimetry suggests reasonably low radiation exposure. On the basis of this study, a clinical 82Rb injection of 2 × 1,480 MBq (80 mCi) would result in a mean effective dose of 3.7 mSv using the weighting factors of the ICRP 103—only slightly above the average annual natural background exposure in the United States (3.1 mSv).